DocWire News Editors

DocwireNews

This retrospective cohort study of cardiac resynchronization therapy (CRT) patients with chronic Chagas cardiomyopathy (CCC) included a comparison of outcomes in patients with CCC who underwent &nbsp;CRT with those of patients with dilated cardiomyopathy and ischemic cardiomyopathies. The primary endpoint was all-cause mortality with a secondary endpoint of NYHA class at 12 months after cardiac resynchronization therapy. There were 115 patients in the CCC group, 177 in the dilated cardiomyopathy group and 134 in the ischemic cardiomyopathy group, with annual mortality rates of 25.4%, 10.4% and 11.3%, respectively (P&lt;0.001). Multivariate analysis shoed that the CCC group had a two-fold higher risk of death compared to the dilated cardiomyopathy group. The researchers concluded that the study results &ldquo;showed that CCC patients submitted to CRT have worse prognosis compared to patients with dilated cardiomyopathy and ischemic cardiomyopathy who undergo CRT.&rdquo;&nbsp;Filho M, Peixoto G, Siqueira S, et al. EP Europace. 2018;doi:10.1093/europace/eux375<a href="https://academic.oup.com/europace/article-abstract/20/11/1813/4917642?redirectedFrom=fulltext">https://academic.oup.com/europace/article-abstract/20/11/1813/4917642?redirectedFrom=fulltext</a>

Sara Nunnery, MD, MSCI

Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?

HER2 Breast Cancer

Meghan Sise, MD

Joel M. Topf, MD, FACP

Redefining Carboplatin Dosing

NKF Spring Clinical Meetings 2025

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Latest News

Analysis: Worse Prognosis for Patients with Chronic Chagas Cardiomyopathy Submitted for CRT

Atrial Fibrillation

This retrospective cohort study of cardiac resynchronization therapy (CRT) patients with chronic Chagas cardiomyopathy (CCC) included a comparison of outcomes in patients with ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe